æ°èªç±ä¸»ç¾©è ã©ãã®æ°åã³ãã対çï½ä¸ã ã®äººã ã«å½ä»¤ããã ã
ã西æ康ç¨çµæ¸åçæ å½ç¸ããæææ¡å¤§ãç¶ãã°å½æ°ã®å½ãå®ããããç·æ¥äºæ 宣è¨ãè¦éã«å ¥ã£ã¦ãããã¨ãã¤ãã¿ã¼ã«æ稿ããããã ããã®ã¾ã¾ã§ã¯ãå»çãæããªããã¨ææããéããªå¹´æ«å¹´å§ãéããããå¼ã³æããã¨ã
ãä½ãä»ããã¨è¨ããããªããå¬ã«çªå ¥ãã¦ããã®ææççºã¯å»çé¢ä¿è ã®èª°ããææãã¦ãããã¨ã§ã¯ãªããããããè¨ããã¨ã¯ãå¤åºãæ§ãããã¨ã¯ãéãã«ä¼é£ãããï¼è ï¼ã¨ããããã«ã人ã ã«å¤åºãæ§ããããã«è¦è«ããã ãããããããã°ãã以å¤ã®ãã¨ã¯ç¸å¤ãããä½ããã£ã¦ããªããç¾½ç°éä¸éè°å¡ãã¤ãå æ¥PCRæ¤æ»ããåããããªãã§æ»å»ããã°ã£ããã§ããã«ããããããã ã
ãç¾½ç°è°å¡ã¯èº«è¿ã«ãã人ã«é½æ§è ãåºãã®ã§ãåè°é¢å ã®è¨ºçæã«æ¤æ»ãåããããªããåãåãããã¨ããããçç¶ããªã人ã«ã¯æ°éã®è¨ºçæã§ããæ¤æ»ã¯åããããªããã¨è¨ããï¼12æ24æ¥ï¼ãPCRæ¤æ»ãã§ããã¯ãªããã¯ã®ãªã¹ãã渡ããããæ¬äººã®ä¸»æ²»å»ãããã«ã¯å«ã¾ãã¦ãããããã§ãæ¤æ»ã¯ã§ããã24æ¥ã®æ·±å¤ã«çºç±ï¼38.6âï¼ãç¿æ¥27æ¥ã®äºå®ã§å¥ã®ã¯ãªããã¯ã«æ¤æ»ãäºç´ããããäºæ¥éèªå® å¾ æ©ã27æ¥ã«æ¤æ»ãåãã«è»ã«ä¹ãè¾¼ãã ã¨ãããããã§å®¹ä½ãæ¥å¤ã亡ããªã£ãã¨ã®ãã¨ã§ããï¼28æ¥ã®ç«æ²æ°ä¸»å ã«ããçºè¡¨ï¼ã
ããã®ãã¨ã¯ãæ°åã³ããã¦ã£ã«ã¹ï¼ä»¥ä¸COVID-19ã¨ç¥ãï¼ã®æææ¡å¤§ãæãè¾¼ãã«ã¯ãç¡çç¶ã®äººããã¤ã§ãã©ãã§ãPCRæ¤æ»ãåããããããã«æ¤æ»ä½å¶ã¨æ¡å ããããã«é½æ§è ããã ã¡ã«æ²»çã§ããããã«å»çä½å¶ãå å®ãããªããã°ãªããªãã¨ãããã¨ã ãããã¯å ¨å½ã®å»çé¢ä¿è ãä»å¹´ã®åãããè¦éãé³´ããã¦ãããã¨ã§ã¯ãªããããããæªã ã«çç¶ãã§ã¦ãæ¤æ»ãåããããªã人ãè¨å¤§ã«ãããã¨ãããã¦ãç¾½ç°æ°ã®ããã«å®¹ä½ãæ¥å¤ãã¦äº¡ããªã£ã人ãå ¨å½ã«è¨å¤§ã«ããã¨æãããã®ã ï¼é ãæ»è ï¼ã
ãããããæ¿åºã¯æ²»çã«æå¹ã¨ããããã¢ãã¬ã³ï¼ãã¡ããã©ãã«ï¼ãæªã ã«æ¿èªãã¦ããªãããã·ã¢ã»ä¸å½ãªã©ããããªå½ã§æ²»çã«ã©ãã©ã使ããã¦ããã®ã«ãã§ããã
ããããã®æ¿åºã®ååãã¿ãã¨ãããã«COVID-19ã®ææé²æ¢ãæå³çã«ãã£ã¦ããªãããããããã¨ãããã®ã ãããã¾ã§ãæ¿åºã¯ãªãªã³ããã¯ããCOVID-19ã«æã¡åã£ã人é¡ã®ç¥å ¸ãã¨ãã¦æ¥æ¬å½å®¶ã®å¨ä¿¡ã示ãããã«å¼·è¡ãããã¨ãã¦ããã®ã ããã®ãã¨ã¯æ°èªç±ä¸»ç¾©è»å ±ã«ãã¹ã¦å ±éãã¦ãããèªæ°å ã®å®åä¸æ´¾ï¼æ¥æ¬ä¼è°ãä¸å¿ã¨ããé£ä¸ï¼ããããç¶æ°ããããããã¦æ±äº¬é½ç¥äºã®å°æ± ãããã§ãããæ©æ¬å¾¹ã¯ãã¾ã ã«æ¤æ»æå¶ãå«ãã§ããã
ããã®ãããªé£ä¸ãæåããªãããããæªæ¥ã¯ãªãã¨æããã©ãã§ããããï¼